Gene therapy maker Sarepta tells FDA it won't halt shipments despite patient deaths
The highly unusual move is a latest in a string of events that have hammered the company's stock for weeks and recently forced it to lay off 500 employees. The company's decision not to comply with the FDA also places future availability of its leading therapy, called Elevidys, in doubt.
The FDA said in a statement Friday night that officials met with Sarepta and requested it suspend all sales but 'the company refused to do so.' The agency has the authority to pull drugs from the market, but the cumbersome regulatory process can take months or even years. Instead, the agency usually makes an informal request and companies almost always comply.
'We believe in access to drugs for unmet medical needs but are not afraid to take immediate action when a serious safety signal emerges,' FDA Commissioner Marty Makary said in a statement.
Elevidys is the first gene therapy approved in the U.S. for Duchenne's muscular dystrophy, the fatal muscle-wasting disease that affects males, though it has faced scrutiny since its clearance in 2023. The one-time treatment received accelerated approval against the recommendations of some FDA scientists who doubted its effectiveness.
The FDA granted full approval last year and expanded the therapy's use to patients 4 years and older, including those who can no longer walk. Previously, it was only available for younger patients who were still walking.
Sarepta said Friday that its scientific review showed 'no new or changed safety signals' for younger patients with Duchenne's who have earlier stages of the disease. The company said it plans to keep the drug available for those patients.
'We look forward to continued discussions and sharing of information with FDA,' the company said in a statement.
Sarepta halted shipments last month of the therapy for older boys with Duchenne's, which gradually destroys muscle and skeletal strength, resulting in early death. The move followed the deaths of two teenage boys taking the therapy.
The company also confirmed a third death Friday: a 51-year-old patient who was taking an experimental gene therapy in a trial for a different form of muscular dystrophy. Sarepta said it reported the death to the FDA on June 20. The FDA said Friday it placed that trial on hold.
Sarepta noted that the gene therapy involved in the incident uses 'a different dose and is manufactured using a different process,' than Elevidys.
All three patient deaths were linked to liver injury, a side effect noted in Sarepta's prescribing information.
Earlier this week Sarepta announced it would add a bold warning to drug and lay off a third of its employees. The company did not mention the third patient death in its news release or conference call announcing those changes, sparking pointed criticism from Wall Street analysts.
Company shares fell more than 35% Friday to close at $14.07.
Cambridge, Massachusetts-based Sarepta has received FDA approval for three other Duchenne's drugs since 2016, none of which have been confirmed to work. The company has long been criticized for failing to complete several studies needed to secure full FDA approval of its drugs.
___
The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Department of Science Education and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New York Times
an hour ago
- New York Times
On Vaccines, Kennedy Has Broken Sharply With the Mainstream
Even before Robert F. Kennedy Jr. took office in February as secretary of the Department of Health and Human Services, some public health experts worried he might use his influence to carry out an anti-vaccine agenda he'd spent decades promoting. In the worst-case scenario, they said, he might dismiss experts on whom the government relies to make sound decisions about immunizations and enact policies restricting access. He might cancel important research that would be needed in a future pandemic. In less than six months, Mr. Kennedy has done all that and more. The health secretary has expressed doubts about childhood vaccines, including those against polio and measles, that have been the mainstay of childhood immunizations for decades. He has described the Covid shot as 'the deadliest vaccine ever made.' Under his leadership, the Food and Drug Administration restricted access to the Covid vaccines for healthy pregnant women and children. And on Tuesday, he canceled nearly $500 million of grants and contracts for work on mRNA vaccines, the technology that helped turn the tide against the coronavirus. Mr. Kennedy explained his decision in a video on social media, claiming falsely that mRNA vaccines offer no protection against respiratory viruses and can prolong pandemics. Most scientists were aghast. His assault on mRNA vaccines, and in particular the Covid vaccines developed in the first Trump administration, may have even riled the president. Want all of The Times? Subscribe.
Yahoo
an hour ago
- Yahoo
Eli Lilly weight loss pill shows promise in latest clinical trial
Eli Lilly, the maker of Zepbound and Mounjaro, said its experimental GLP-1 pill successfully helped adults with obesity lose weight in a Phase 3 trial, as the company moves closer to submitting the drug for approval from the Food and Drug Administration. In a news release Thursday, the drugmaker said the oral medication, called orforglipron, helped adults lose an average of 27.3 pounds in a 72-week trial. The pill showed "significant efficacy, and a safety and tolerability profile consistent with injectable GLP-1 therapies," the release added. The results shared by Eli Lilly, which have not been peer reviewed and published as of Thursday morning, are "on par with what we see with the injectable forms of these drugs," Dr. Céline Gounder, CBS News medical contributor and editor-at-large for public health at KFF Health News, said on "CBS Mornings" Thursday. Some investors, however, were disappointed with the results Eli Lilly provided. Shares of the company were down about 13.9% Thursday morning. Also like the injectables, the pill showed some side effects among participants, with the most commonly reported issues being nausea, vomiting, diarrhea and constipation. "About 10% of people who are taking the highest dose, which is also what got you that high level of weight loss ... were unable to continue, had to stop, due to the side effects," Gounder said. Eli Lilly said it is on track to submit orforglipron to regulatory agencies like the FDA for approval later this year, which means it could be available to consumers in 2026, Gounder said. It is unclear how much the drug will cost, but Gounder said she expected it to cost less than injectables. A pill would be a "game changer" in terms of accessibility, she said. "With the injectables, you need needles. You need to be able to refrigerate," she said. "What's great about the pills is it's a lot cheaper to manufacture a pill. It's a lot easier to take, and there are no restrictions around, you have to take it with water, with food. You can take it at any time of day. So this will make it a lot more accessible to people, both in terms of cost as well as convenience." Earlier this year, orforglipron's efficacy and safety was measured in a trial with adults who have Type 2 diabetes, showing positive results. Sneak peek: The Strange Shooting of Alex Pennig Neil deGrasse Tyson weighs in on plans for a moon-based nuclear reactor "Platonic" stars talk about new season and maintaining friendships as adults Solve the daily Crossword
New York Post
an hour ago
- New York Post
Americans eat half their calories from ultra-processed foods, CDC says
Most Americans get more than half their calories from ultra-processed foods, those super-tasty, energy-dense foods typically full of sugar, salt, and unhealthy fats, according to a new federal report. Nutrition research has shown for years that ultra-processed foods make up a big chunk of the U.S. diet, especially for kids and teens. For the first time, however, the U.S. Centers for Disease Control and Prevention has confirmed those high levels of consumption, using dietary data collected from August 2021 to August 2023. Advertisement 6 Most Americans get more than half their calories from ultra-processed foods, according to a new federal report. AP The report comes amid growing scrutiny of such foods by Health Secretary Robert F. Kennedy Jr., who blames them for causing chronic disease. 'We are poisoning ourselves and it's coming principally from these ultra-processed foods,' Kennedy told Fox News earlier this year. Overall, about 55% of total calories consumed by Americans age 1 and older came from ultra-processed foods during that period, according to the report. For adults, ultra-processed foods made up about 53% of total calories consumed, but for kids through age 18, it was nearly 62%. Advertisement The top sources included burgers and sandwiches, sweet baked goods, savory snacks, pizza, and sweetened drinks. Young children consumed fewer calories from ultra-processed foods than older kids, the report found. Adults 60 and older consumed fewer calories from those sources than younger adults. Low-income adults consumed more ultra-processed foods than those with higher incomes. Advertisement The results were not surprising, said co-author Anne Williams, a CDC nutrition expert. 6 Overall, about 55% of total calories consumed by Americans age 1 and older came from ultra-processed foods during that period, according to the report. Roman – What was surprising was that consumption of ultra-processed foods appeared to dip slightly over the past decade. Among adults, total calories from those sources fell from about 56% in 2013-2014 and from nearly 66% for kids in 2017-2018. Williams said she couldn't speculate about the reason for the decline or whether consumption of less processed foods increased. Advertisement But Andrea Deierlein, a nutrition expert at New York University who was not involved in the research, suggested that there may be greater awareness of the potential harms of ultra-processed foods. 6 The top sources included burgers and sandwiches, sweet baked goods, savory snacks, pizza, and sweetened drinks. Shutterstock 'People are trying, at least in some populations, to decrease their intakes of these foods,' she said. Concern over ultra-processed foods' health effects has been growing for years, but finding solutions has been difficult. Many studies have linked them to obesity, diabetes and heart disease, but they haven't been able to prove that the foods directly cause those chronic health problems. One small but influential study found that even when diets were matched for calories, sugar, fat, fiber and micronutrients, people consumed more calories and gained more weight when they ate ultra-processed foods than when they ate minimally processed foods. 6 For adults, ultra-processed foods made up about 53% of total calories consumed, but for kids through age 18, it was nearly 62%. Meritxell Cid – Research published this week in the journal Nature found that participants in a clinical trial lost twice as much weight when they ate minimally processed foods — such as pasta, chicken, fruits and vegetables — than ultra-processed foods, even those matched for nutrition components and considered healthy, such as ready-to-heat frozen meals, protein bars and shakes. Advertisement Part of the problem is simply defining ultra-processed foods. The new CDC report used the most common definition based on the four-tier Nova system developed by Brazilian researchers that classifies foods according to the amount of processing they undergo. 6 Research found that participants in a clinical trial lost twice as much weight when they ate minimally processed foods — such as pasta, chicken, fruits and vegetables — than ultra-processed foods. nerudol – Such foods tend to be 'hyperpalatable, energy-dense, low in dietary fiber and contain little or no whole foods, while having high amounts of salt, sweeteners and unhealthy fats,' the CDC report said. Advertisement U.S. health officials recently said there are concerns over whether current definitions 'accurately capture' the range of foods that may affect health. The U.S. Food and Drug Administration and the Agriculture Department recently issued a request for information to develop a new, uniform definition of ultra-processed foods for products in the U.S. food supply. 6 U.S. health officials recently said there are concerns over whether current definitions 'accurately capture' the range of foods that may affect health. juliasudnitskaya – In the meantime, Americans should try to reduce ultra-processed foods in their daily diets, Deierlein said. Advertisement For instance, instead of instant oatmeal that may contain added sugar, sodium, artificial colors, and preservatives, use plain oats sweetened with honey or maple syrup. Read food packages and nutrition information, she suggested. 'I do think that there are less-processed options available for many foods,' she said.
